Masimo | MASI - Operating Expenses

Stock Price
178.63
Daily Change
-0.08 -0.04%
Monthly
0.30%
Yearly
9.09%
Q2 Forecast
174.81

Masimo reported $328.6M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Abbott USD 9.31B 104M Mar/2026
Accuray USD 37.18M 567K Dec/2024
Align Technology USD 822.85M 11.8M Dec/2025
AngioDynamics USD 81.95M 1.68M Sep/2025
Artivion USD 111.2M 9.45M Dec/2025
AtriCure USD 138.01M 3.95M Dec/2025
Avanos Medical USD 156.13M 2.7M Dec/2025
Baxter International USD 3.19B 554.4M Dec/2025
Becton, Dickinson and Co. USD 4.59B 476M Dec/2025
Boston Scientific USD 4.04B 18M Dec/2025
Dexcom USD 936.6M 30.2M Dec/2025
Edwards Lifesciences USD 1.13B 65.4M Mar/2026
General Electric Aerospace USD 18.06B 7.11B Mar/2026
Globus Medical USD 645.11M 241.46M Dec/2025
Haemonetics USD 134.99M 1.26M Dec/2025
Inogen USD 49.14M 665K Sep/2024
Insulet USD 637.5M 48.9M Dec/2025
Integra LifeSciences USD 368.92M 668.65M Dec/2025
Intuitive Surgical USD 1.91B 89.8M Mar/2026
Masimo USD 328.6M 181.6M Dec/2025
Medtronic USD 7.28B 16M Dec/2025
Orthofix International USD 213.79M 12.36M Dec/2025
Owens Minor USD 708.15M 1.14B Dec/2025
ResMed USD 925.21M 51.98M Dec/2025
Steris USD 1.22B 28.8M Dec/2025
Stryker USD 5.2B 505M Dec/2025
Tandem Diabetes Care USD 282.09M 9.97M Dec/2025
Teleflex USD 532.64M 3.29B Dec/2025
Thermo Fisher Scientific USD 9.09B 821M Mar/2026
Zimmer Biomet Holdings USD 1.94B 277.8M Dec/2025